Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Other Non-Current Assets: 2010-2025

Historic Other Non-Current Assets for Altimmune (ALT) over the last 14 years, with Sep 2025 value amounting to $1.5 million.

  • Altimmune's Other Non-Current Assets fell 9.89% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 9.89%. This contributed to the annual value of $1.6 million for FY2024, which is 351.52% up from last year.
  • As of Q3 2025, Altimmune's Other Non-Current Assets stood at $1.5 million, which was down 4.41% from $1.6 million recorded in Q2 2025.
  • Altimmune's 5-year Other Non-Current Assets high stood at $1.7 million for Q2 2024, and its period low was $115,300 during Q1 2021.
  • In the last 3 years, Altimmune's Other Non-Current Assets had a median value of $1.5 million in 2025 and averaged $1.1 million.
  • In the last 5 years, Altimmune's Other Non-Current Assets skyrocketed by 968.76% in 2021 and then crashed by 45.24% in 2024.
  • Altimmune's Other Non-Current Assets (Quarterly) stood at $872,000 in 2021, then fell by 29.47% to $615,000 in 2022, then slumped by 40.98% to $363,000 in 2023, then soared by 351.52% to $1.6 million in 2024, then declined by 9.89% to $1.5 million in 2025.
  • Its Other Non-Current Assets was $1.5 million in Q3 2025, compared to $1.6 million in Q2 2025 and $1.6 million in Q1 2025.